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I’d like to take this opportunity at the beginning of my
tenure as Editor-in-Chief of Biology of Blood and Marrow
Transplantation (BBMT) to reﬂect on both the accomplish-
ments of the past and our prospects for the journal’s future.
BBMT has grown steadily in volume and stature since its
inception in 1994. This development has been largely due to
the strong dedicated efforts of the past co-editors—initially
Dr. Richard O’Reilly and, more recently, Dr. Karl Blume.
On behalf of the American Society for Blood and Marrow
Transplantation (ASBMT) and on a personal level, I would
like to extend our gratitude to the co-editors for steering the
journal to this decisive point. Starting as a 6-issue-per-year
publication, BBMT has grown in the past year to an 11-issue-
per-year publication. BBMT is also now fully indexed by
MEDLINE, Citation Index, ISI Alerting, and Current Con-
tents/Clinical Medicine. This achievement also reﬂects, in
no small part, the outstanding work of the Associate Editors
and the members of the Editorial Board, who have held the
quality of the manuscripts to a high standard and have expe-
ditiously handled the review process. I would also like to
thank all of the authors who, by submitting their manu-
scripts, demonstrated their active commitment to the suc-
cess of the journal and of the Society.
My future goals are to continue the trend of publishing
high-caliber manuscripts and to gradually expand the num-
ber of articles per issue. Meeting these goals depends, of
course, on you the members of the ASBMT. I urge you to
participate in helping to make BBMT the premier journal
for the ﬁeld of marrow and hematopoietic stem cell trans-
plantation. We are at a pivotal point in time when the ﬁeld
is about to dramatically expand in several new directions.
Recent advances in stem cell isolation, nonmyeloablative
conditioning regimens, and research efforts in the immuno-
logical manipulation of donor T cells have extended the
potential application of transplantation to a wider range of
patients, including those with solid tumors and autoimmune
diseases. As the ﬁeld continues to expand, we ﬁrmly believe
that BBMT should serve as the primary source of scientiﬁc
communication. BBMT is unique in seeking to focus on
both basic and clinical research in blood and marrow trans-
plantation. The ASBMT includes within its ranks many
members from the academic-based transplant centers that
lead the ﬁeld in development. Therefore, there is no better
vehicle for conveying to all participants the latest innovative
approaches and new insights into an understanding of the
immunobiology of rejection, graft-versus-host disease,
reconstitution, infections, graft-versus-leukemia responses,
and a wide range of related issues. I encourage all members
of the Society to select BBMT as their ﬁrst choice for sub-
mission of manuscripts to maximize their inﬂuence on the
field and directly reach those investigators who can best
appreciate their scientiﬁc contribution. At the same time, I
would also like to invite submission of review articles on any
relevant transplantation issue. I extend both of these appeals
to the international community of transplantation investiga-
tors because we fully intend to increase BBMT’s worldwide
impact. In conclusion, I look forward to the continued
growth and success of BBMT, and with your utmost cooper-
ation, the journal will serve as a source of pride for all mem-
bers of the ASBMT.
Robert Korngold
Editor-in-Chief
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